Meanwhile, CyPA level in plasma analyzed by ELISA was significantly higher in severe/critical COVID-19 patients (n = 106, comprising the above 41 severe/critical cases) than in mild (n = 159) and healthy cohorts (n = 100) (Fig. 5i). The gene discussed is PPIA; the disease is COVID-19.